760
O. Rorlik et al. / Tetrahedron Letters 52 (2011) 757–760
10. All the reactions were performed in the presence of a constant concentration of
Acknowledgments
1,3,5-tribromobenzene (internal standard) and the yields of both products
were estimated by comparing the area of the peak of the vinylic hydrogens of
the products (by 1H NMR) to the area of the peak of the internal standard.
11. Representative procedure: Preparation of 3,5-dibromo-1-n-hexyl-1H-pyridine-
4,4-dicarboxylic acid dimethyl ester (4a). Compound 2a (2.0 g, 0.00712 mol)
and pyridine (0.115 mL, 0.0142 mol) were dissolved in distilled CH2Cl2 (50 mL).
This work was partially supported by a grant from the Institute
of Drug Research. O.R. was the recipient of a fellowship from the
School of Pharmacy, Hebrew University.
The mixture was cooled to 0 °C under
a nitrogen atmosphere. Bromine
(0.73 mL, 0.0142 mol) dissolved in distilled CH2Cl2 (10 mL) was added, over
30 min, to the reaction mixture and after 10 min the mixture was diluted with
aqueous HCl (0.1 M) and washed with CH2Cl2 (3 ꢀ 100 ml). The organic phase
was dried aver MgSO4 and the solvent was evaporated. The product was
separated by column chromatography on silica gel (7% EtOAc in petroleum
ether). The resulting white powder was recrystallized from hot CH3CN to give
4a (1.84 g, 59%) as a white crystalline solid: mp 66–67 °C; 1H NMR (300 MHz,
CDCl3) d 6.47 (s, 2H), 3.83 (s, 6H) 3.17 (t, J = 4.5 Hz, 2H), 1.54 (m, 2H), 1.26 (m,
6H), 0.88 (t, J = 3.6 Hz, 3H); 13C NMR (75 MHz, CDCl3) d 168.24, 132.19, 88.99,
65.57, 54.33, 53.29, 31.49, 30.39, 26.06, 22.67, 14.16; ESI m/z 900.95 (2M+Na)+,
461.97 (M+Na)+, 439.98 (M+H)+; HRMS calcd for C15H21NO4Br2 ([M+H]+)
439.98896, found 439.98962.
Supplementary data
Supplementary data associated with this article can be found, in
References and notes
1. Romero, M.; Sanchez, I.; Pujol, M. D. Curr. Med. Chem. 2003, 1, 113–141.
2. Schramm, M.; Thomas, G.; Towart, R.; Franckowiak, G. Nature 1983, 303, 535–
537.
3. Loev, B.; Goodman, M. M.; Snader, K. M.; Tedeschi, R.; Macko, E. J. Med. Chem.
1974, 17, 956–965.
4. Yamagishi, S.; Matsui, T.; Nakamura, K. Med. Hypotheses 2007, 68, 1096–1098.
5. Hantzsch, A. Justus Liebigs Ann. Chem. 1882, 215, 1.
6. Reddy, G. M.; Shiradkar, M.; Chakravarthy, A. K. Curr. Org. Chem. 2007, 11, 847–
852.
7. Kato, T.; Tejima, M.; Ebiike, H.; Achiwa, K. Chem. Pharm. Bull. 1996, 44, 1132–
1134.
12. Preparation of 1-cyclopentyl-3,5-diphenyl-1H-pyridine-4,4-dicarboxylic acid
dimethyl ester (6). Compound 4a (100 mg, 0.236 mmol), phenylboronic acid
(115.2 mg, 0.944 mmol), KOH (52.8 mg, 0.944 mmol), and PdCl2 were mixed in
distilled toluene. The mixture was stirred at 110 °C, under
a nitrogen
atmosphere, for 2 d. The product was purified by column chromatography on
silica gel (10% EtOAc in petroleum ether) to give 6 (69 mg, 70%) a yellow solid:
mp 145–149 °C; 1H NMR (300 MHz, CDCl3) d 7.46 (d, J = 6 Hz, 4H), 7.16–7.30
(m, 6H) 6.56 (s, 2H), 3.91 (m, 1H), 3.42 (s, 6H), 2.05 (m, 2H), 1.52–1.79 (m, 6H);
13C NMR (75 MHz, CDCl3) d 172.02, 138.64, 128.33, 128.25, 128.22, 128.17,
126.53, 108.67, 64.41, 52.70, 32.30, 24.22; ESI m/z 873.35 (2M+K)+, 456.15
(M+K)+; HRMS calcd for C26H27NO4 ([M+Na]+) 440.18323, found 440.18350.
8. Oba, M.; Tanaka, M.; Takano, Y.; Suemune, H. Tetrahedron 2005, 61, 593–598.
9. These conditions were selected after running the reaction with different bases,
at various temperatures and in different solvents.